Skip to content

Establishment of diagnosis method of ischemic heart disease in patients with hemophilia and HIV

Establishment of diagnosis method of ischemic heart disease in patients with hemophilia and HIV - Hem-IHD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035307
Enrollment
50
Registered
2018-12-21
Start date
2019-01-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemophilia with HIV

Interventions

Sponsors

National Center for Global Health and Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Person who understands this research study and consents in the agreement form 2. Person who has been diagnosed as hemophilia 3. Person with HIV positive result

Exclusion criteria

Exclusion criteria: 1. Person who has a history of hypersensitivity to iodine or iodine contrast medium 2. Person contraindicated or in principle contraindicated for the use of contrast agents such as severe renal dysfunction 3. Person who has a possibility of pregnancy 4. Those who have judged that the research director is inappropriate for inclusion in this research

Design outcomes

Primary

MeasureTime frame
Prevalence of ischemic heart disease in hemophilia with HIV

Secondary

MeasureTime frame
Correlation between risk factors and ischemic heart disease in hemophilia with HIV

Countries

Japan

Contacts

Public ContactYukio Hiroi

National Center for Global Health and Medicine, Center Hospital Cardiology

yhiroi@hosp.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026